Computer-assisted analysis of the interactions of macrocyclic inhibitors with wild type and mutant D168A hepatitis C virus NS3 serine protease

被引:14
作者
da Cunha, EFF
Ramalho, TC
Taft, CA
de Alencastro, RB
机构
[1] Univ Fed Rio de Janeiro, LABMMOL, Dept Quim Organ, Inst Quim,Ctr Tecnol, BR-21949900 Rio de Janeiro, Brazil
[2] Univ Fed Lavras, Dept Quim, BR-37200000 Lavras, MG, Brazil
[3] CBPF, BR-22290180 Rio De Janeiro, Brazil
关键词
hepatitis C virus NS3 protease; BILN; 2061; CoMFA; FlexX;
D O I
10.2174/157018006775240953
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The high frequency of treatment failures suggests the need for more specific, less toxic and more active antiviral therapies for the Hepatitis C virus (HCV). HCV NS3 is currently regarded as a prime target for anti-viral drugs, thus, molecular modeling studies were used to try to understand the interaction of BILN 2061 macrocyclic analogs with the wild-type and the D168A mutant NS3 serine protease, with the aim of rendering them better therapeutic agents of the Hepatitis C virus infection.
引用
收藏
页码:17 / 28
页数:12
相关论文
共 26 条
[1]   Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model, (Retraction of vol 97, pg 297, 2000) [J].
Arichi, T ;
Saito, T ;
Major, ME ;
Belyakov, IM ;
Shirai, M ;
Engelhard, VH ;
Feinstone, SM ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5943-5943
[2]   BILN 2061: a major step toward new therapeutic strategies in hepatitis C [J].
Asselah, T ;
Marcellin, P .
JOURNAL OF HEPATOLOGY, 2004, 41 (01) :178-181
[3]   Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease [J].
Chen, KX ;
Njoroge, FG ;
Prongay, A ;
Pichardo, J ;
Madison, V ;
Girilavallabhan, V .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) :4475-4478
[4]   COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) .1. EFFECT OF SHAPE ON BINDING OF STEROIDS TO CARRIER PROTEINS [J].
CRAMER, RD ;
PATTERSON, DE ;
BUNCE, JD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (18) :5959-5967
[5]   The search for new DHFR inhibitors: a review of patents, January 2001 February 2005 [J].
da Cunha, EFF ;
Ramalho, TC ;
Mala, ER ;
de Alencastro, RB .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (08) :967-986
[6]   4D-QSAR models of HOE/BAY-793 analogues as HIV-1 protease inhihitors [J].
da Cunha, EFF ;
Albuquerque, MG ;
Antunes, OAC ;
de Alencastro, RB .
QSAR & COMBINATORIAL SCIENCE, 2005, 24 (02) :240-253
[7]   Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases [J].
da Cunha, EFF ;
Ramalho, TC ;
de Alencastro, RB ;
Maia, ER .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2004, 22 (02) :119-130
[8]   Peptides and proteins in membranes: What can we learn via computer simulations? [J].
Efremov, RG ;
Nolde, DE ;
Konshina, AG ;
Syrtcev, NP ;
Arseniev, AS .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (18) :2421-2442
[9]  
FOLKERS G, 1993, COMFA SCOPE LIMITATI, P583
[10]   HCVNS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen [J].
Gal-Tanamy, M ;
Zemel, R ;
Berdichevsky, Y ;
Bachmatov, L ;
Tur-Kaspa, R ;
Benhar, I .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 347 (05) :991-1003